FDA Advisers On Yaz Had Ties To Bayer: Ex-Agency Chief

Law360, New York (January 11, 2012, 1:45 PM EST) -- Some U.S. Food and Drug Administration advisers who voted that Bayer AG's Yasmin, Yaz and other birth control pills were more beneficial than harmful had improper ties to the drugmaker, an ex-FDA chief asserted in testimony unsealed last week in an Illinois federal court overseeing multidistrict litigation.

Both the testimony and Bayer's motion to strike it were unsealed Jan. 3 in an MDL that brings together about 10,000 cases filed across the country arguing that Bayer's Yaz and Yasmin oral contraceptives were responsible for blood clots,...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.